| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | brinzolamide/brimonidine (Simbrinza®) |
| Formulation | 10 mg/ml/2 mg/ml eye drops |
| Reference number | 2144 |
| Indication | Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction |
| Company | Alcon Laboratories (UK) Ltd |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 05/08/2014 |